INDIAN FIRMS MUSCLING IN ON US MARKET

JUNE 01, 2007
India?s bustling pharmaceutical industry is carving an increasingly noticeable niche in the generic drug market as big money prescription medicines lose patent protection in the United States. According to one recent analysis, 12 Indian drug manufacturers (including Aurobindo Pharma Ltd, Wockhardt, Ranbaxy Pharmaceuticals Inc, Dr Reddy?s Laboratories Ltd, and Sun Pharmaceutical Industries Ltd) have managed to snag almost 25% of all US generic drug approvals issued by the FDA during the first 4.5 months of 2007. During the same period last year, Indian firms accounted for less than 17% of US generic drug approvals.

SHARE THIS SHARE THIS
0
 

The Oncology Care Pharmacist in Health-System Pharmacy 
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.